申请人:The Procter & Gamble Company
公开号:US04708966A1
公开(公告)日:1987-11-24
The present invention relates to novel specifically-substituted phenyl compounds, especially substituted di-tert-butyl phenol derivatives, which are effective as anti-inflammatory, analgesic and/or antipyretic agents. These phenyl compounds are substituted with a low molecular weight alkyl chain which terminates in a specific unsaturated functional group. These unsaturated functionalities are --C.tbd.CH, C.dbd.CH.sub.2, C.dbd.C.dbd.CH.sub.2, and aldehydes in the form of their acetals. The present invention further relates to pharmaceutical compositions which contain an anti-inflammatory agent of the present invention and a pharmaceutically-acceptable carrier. Finally, the present invention relates to methods for treating diseases characterized by inflammation, such as rheumatoid arthritis and osteoarthritis, in humans or lower animals. Such methods comprise administering to a human or lower animal in need of such treatment a safe and effective amount of an anti-inflammatory agent or composition of the present invention.
本发明涉及一种新型的特定取代苯基化合物,特别是取代的二叔丁基酚衍生物,其作为抗炎、镇痛和/或退热剂具有良好的效果。这些苯基化合物被低分子量烷基链取代,该链以特定的不饱和官能团结束。这些不饱和官能团包括--C.tbd.CH,C.dbd.CH.sub.2,C.dbd.C.dbd.CH.sub.2以及以其缩醛的形式。本发明还涉及含有本发明的抗炎药物和医药上可接受的载体的制药组合物。最后,本发明涉及用于治疗以炎症为特征的疾病,如类风湿性关节炎和骨关节炎等人类或低等动物的方法。这些方法包括向需要此类治疗的人类或低等动物投予本发明的抗炎药物或组合物的安全有效量。